Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

OBJECTIVE: To report safety and efficacy outcomes from up to 9 years of treatment with teriflunomide in an extension (NCT00803049) of the pivotal phase 3 Teriflunomide Multiple Sclerosis Oral (TEMSO) trial (NCT00134563). METHODS: A total of 742 patients entered the extension. Teriflunomide-treated p...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Connor, Paul, Comi, Giancarlo, Freedman, Mark S., Miller, Aaron E., Kappos, Ludwig, Bouchard, Jean-Pierre, Lebrun-Frenay, Christine, Mares, Jan, Benamor, Myriam, Thangavelu, Karthinathan, Liang, Jinjun, Truffinet, Philippe, Lawson, Victoria J., Wolinsky, Jerry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782117/
https://www.ncbi.nlm.nih.gov/pubmed/26865517
http://dx.doi.org/10.1212/WNL.0000000000002441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782117/
https://www.ncbi.nlm.nih.gov/pubmed/26865517
http://dx.doi.org/10.1212/WNL.0000000000002441

Ejemplares similares